institute of virology (viro)

Font size »A . A+ . A++ .

Publications 2003

 

 

  • Anderson CE, Tomlinson GS, Pauly B, Brannan FW, Chiswick A, Brack-Werner R, Simmonds P, Bell JE: Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection. Neuropathol Appl Neurobio. 2003, 29: 378-388.
  • Bronte V, Serafini P, De Santo C, Marigo I, Tosello V, Mazzoni A, Segal DM, Staib C, Löwel M, Sutter G, Colombo MP, Zanovello P: IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol. 2003, 170: 270-278.
  • Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I, Sutter G, Huber S, Seliger B: Functional role of human leukocyte antigen-G up-regulation in renal Cell carcinoma. Cancer Res. 2003, 63: 4107-4111.
  • Cosma A, Nagaraj R, Bühler S, Hinkula J, Busch DH, Sutter G, Goebel FD, Erfle V: Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals. Vaccine. 2003, 22: 21-29.
  • Demart S, Ceccherini-Silberstein F, Schlicht S, Walcher S, Wolff H, Neumann M, Erfle V, Brack-Werner R: Analysis of nuclear targeting activities of transport signals in the human immunodeficiency virus Rev protein. Exp Cell Res. 2003, 291: 484-501.
  • Di Nicola M, Carlo-Stella C, Anichini A, Mortarini R, Guidetti A, Tragni G, Gallino F, Del Vecchio M, Ravagnani F, Morelli D, Chaplin P, Arndtz N, Sutter G, Drexler I, Parmiani G, Cascinelli N, Gianni AM: Immunization of patients with malignant melanoma with autologous CD 34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient Vaccinia vector encoding the human Tyrosinase Gene: A phase I trial. Hum Gene Ther. 2003, 14: 1347-1360.
  • Drexler I, Staib C, Kastenmüller W, Stevanovic S, Schmidt B, Lemonnier FA, Rammensee HG, Busch DH, Bernhard H, Erfle V, Sutter G: Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc Natl Acad Sci USA. 2003, 100: 217-222.
  • Guenzi E, Töpolt K, Lubeseder-Martellato C, Jörg A, Naschberger E, Benelli R, Albini A, Stürzl M: The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 2003, 22: 3772-3782.
  • Hornemann S, Harlin O, Staib S, Kisling S, Erfle V, Kaspers B, Häcker G, Sutter G: Replication of modified Vaccinia Virus Ankara in primary chicken embryo fibroblasts requires expression of the Interferon resistance gene E3L. J Virol. 2003, 77: 8394-8407.
  • Klöcker U, Kürschner T, Oberwinkler H, Protzer U: Presence of replicating virus in recombinant hepadnavirus stocks results from homologous recombination and can be eliminated be the use of a packaging cell line. J Virol. 2003, 77/5: 2873-2881.
  • Marquart KH: Curvilinear membranous formations in Lymph Node Cells of an African AIDS patient with tuberculosis. Ultrastruct Pathol. 2003, 27: 49-53.
  • Meiser A, Boulanger D, Sutter G, Krijnse Locker J: Comparison of virus production in chicken embryo fibroblasts infected with WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi-network wrapping and extracellular enveloped virus release. J Gen Virol. 2003, 84: 1383-1392.
  • Öhlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib S, Sutter G, Gissmann L: Human Papillomavirus Type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 Mice. J Virol. 2003, 77: 4635-4645
  • Ponsel D, Bruss V: Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol. 2003, 77:416-422.
  • Ritz U, Drexler I, Sutter G, Abele R, Huber C, Seliger B: Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP Subunit TAP1. J Immunol. 2003, 170: 941-946.
  • Schulze-Bergkamen H, Untergasser A, Dax A, Vogel H, Büchler P, Klar E, Lehnert T, Friess H, Büchler M, Kirschfink M, Stremmel W, Krammer P, Müller M, Protzer U: Primary human hepatocytes - a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol. 2003, 38: 736-744.
  • Seifarth W, Spiess B, Zeilfelder U, Speth C, Hehlmann R, Leib-Mösch C: Assessment of retroviral activity using a universal retrovirus chip. J Virol Methods 2003, 112: 79-91.
  • Spiess B, Buchheit D, Baust C, Skladny H, Seifarth W, Zeifelder U, Leib-Mösch C, Morz H, Hehlmann R: Development of a LightCycler PCR Assay for detection and quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients. J Clin Microbiol. 2003, 41: 1811-1818.
  • Staib C, Löwel M, Erfle V, Sutter G: Improved host range selection for recombinant modified Vaccinia Virus Ankara. Biotechniques 2003 34/4: 694-6, 698, 700.
  • Staib C, Sutter G: Live viral vectors: vaccinia virus. Methods Mol Med. 2003, 87: 51-68.
  • Sutter G, Staib C: Vaccinia Vectors as Candidate Vaccines: The development of modified Vaccinia Virus Ankara for Antigen Delivery. Curr Drug Targets Infect Disord. 2003, 3: 263-271.
  • Vogel TU, Reynolds MR, Fuller DH, Vielhuber K, Shipley T, Fuller JT, Kunstman KJ, Sutter G, Marthas ML, Erfle V, Wolinsky SM, Wang C, Allison DB, Rud EW, Wilson N, Montefiori D, Altman JD, Watkins DI: Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol. 2003, 77/24:13348-60.
  • Wolff H, Brack-Werner R, Neumann M, Werner T, Schneider R: Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS. Nucleic Acids Res. 2003, 31: 2839-2851.